Literature DB >> 26701172

Post-chemotherapy laparoscopic retroperitoneal lymph node dissection is feasible for stage IIA/B non-seminoma germ cell tumors.

Terukazu Nakamura1, Akihiro Kawauchi2, Masakatsu Oishi3, Takashi Ueda3, Takumi Shiraishi3, Hiroyuki Nakanishi3, Kazumi Kamoi3, Yoshio Naya3, Fumiya Hongo3, Koji Okihara3, Tsuneharu Miki3.   

Abstract

OBJECTIVE: To assess the efficacy, outcome and complications of post-chemotherapy laparoscopic retroperitoneal lymph node dissection (L-RPLND) for stage IIA/B testicular germ cell tumor (GCT) patients in comparison with open RPLND (O-RPLND).
METHODS: L-RPLND was performed in 14 patients with stage IIA/B non-seminoma GCTs among 154 non-seminoma patients who received RPLND after completion of chemotherapy with tumor marker normalization at our institution between 1998 and 2013. Their outcomes were compared with those of 14 patients with stage IIA/B non-seminoma GCTs treated with O-RPLND during the same period. Clinical parameters were compared between L-RPLND and O-RPLND.
RESULTS: There were no significant differences in the background characteristics of the two groups except for follow-up duration (36 months for L-RPLND, 70 months for O-RPLND; p = 0.02). Blood loss during surgery was significantly less for the L-RPLND group than for the O-RPLND group (155 mL for L-RPLND, 700 mL for O-RPLND; p < 0.001). Parameters related to post-operative recovery were significantly better for the L-RPLND group than for the O-RPLND group. Histopathological examination showed no difference between the two groups. Neither group had disease recurrence.
CONCLUSION: Post-chemotherapy L-RPLND with a bilateral template and nerve-sparing method was safe, effective, and showed a high preservation rate of antegrade ejaculation with no deterioration of outcomes compared to O-RPLND.

Entities:  

Keywords:  Germ cell tumors; Laparoscopic retroperitoneal lymph node dissection; Non-seminoma; Post-chemotherapy; Stage IIA/B

Mesh:

Substances:

Year:  2015        PMID: 26701172     DOI: 10.1007/s10147-015-0934-0

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN: 1341-9625            Impact factor:   3.402


  22 in total

1.  Residual tumor size and IGCCCG risk classification predict additional vascular procedures in patients with germ cell tumors and residual tumor resection: a multicenter analysis of the German Testicular Cancer Study Group.

Authors:  Christian Winter; David Pfister; Jonas Busch; Cigdem Bingöl; Ulrich Ranft; Mark Schrader; Klaus-Peter Dieckmann; Axel Heidenreich; Peter Albers
Journal:  Eur Urol       Date:  2011-11-07       Impact factor: 20.096

2.  External validation of the Heidenreich criteria for patient selection for unilateral or bilateral retroperitoneal lymph node dissection for post-chemotherapy residual masses of testicular cancer.

Authors:  Cédric Vallier; Pierre-Henri Savoie; Jean-Robert Delpero; Franck Bladou; Gwenaëlle Gravis; Naji Salem; Dominique Rossi; Jochen Walz
Journal:  World J Urol       Date:  2014-01-20       Impact factor: 4.226

3.  International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group.

Authors: 
Journal:  J Clin Oncol       Date:  1997-02       Impact factor: 44.544

4.  Extraperitoneal laparoscopic para-aortic lymph node dissection for early stage nonseminomatous germ cell tumors of the testis with introduction of a nerve sparing technique: description and results.

Authors:  E LeBlanc; A Caty; D Dargent; D Querleu; E Mazeman
Journal:  J Urol       Date:  2001-01       Impact factor: 7.450

5.  Postchemotherapy laparoscopic retroperitoneal lymph node dissection for nonseminomatous germ cell tumors infiltrating the great vessels.

Authors:  Stefan Aufderklamm; Tilman Todenhöfer; Joerg Hennenlotter; Johannes Mischinger; Johannes Böttge; Steffen Rausch; Omar Halalsheh; Arnulf Stenzl; Georgios Gakis; Christian Schwentner
Journal:  J Endourol       Date:  2014-02-14       Impact factor: 2.942

6.  Is full bilateral retroperitoneal lymph node dissection always necessary for postchemotherapy residual tumor?

Authors:  Stephen D W Beck; Richard S Foster; Richard Bihrle; John P Donohue; Lawrence H Einhorn
Journal:  Cancer       Date:  2007-09-15       Impact factor: 6.860

7.  Incidence of metastatic nonseminomatous germ cell tumor outside the boundaries of a modified postchemotherapy retroperitoneal lymph node dissection.

Authors:  Brett S Carver; Bobby Shayegan; Scott Eggener; Jason Stasi; Robert J Motzer; George J Bosl; Joel Sheinfeld
Journal:  J Clin Oncol       Date:  2007-10-01       Impact factor: 44.544

8.  Postchemotherapy laparoscopic retroperitoneal lymph node dissection in nonseminomatous germ-cell tumor.

Authors:  Jean-Patrice Calestroupat; Rafael Sanchez-Salas; Xavier Cathelineau; Francois Rozet; Marc Galiano; Gordon Smyth; Ali Kasraeian; Eric Barret; Guy Vallancien
Journal:  J Endourol       Date:  2009-04       Impact factor: 2.942

9.  Post-chemotherapy laparoscopic retroperitoneal lymph-node dissection in testis cancer patients.

Authors:  Rafael Maldonado-Valadez; David Schilling; Aristotelis G Anastasiadis; Wolfgang Sturm; Arnulf Stenzl; Stefan Corvin
Journal:  J Endourol       Date:  2007-12       Impact factor: 2.942

10.  Bilateral laparoscopic postchemotherapy retroperitoneal lymph-node dissection in nonseminomatous germ cell tumors--a comparison to template dissection.

Authors:  Stefan Aufderklamm; Tilman Todenhöfer; Jörg Hennenlotter; Georgios Gakis; Johannes Mischinger; Jens Mundhenk; Miriam Germann; Arnulf Stenzl; Christian Schwentner
Journal:  J Endourol       Date:  2013-06-11       Impact factor: 2.942

View more
  2 in total

1.  Laparoscopic retroperitoneal lymph node dissection versus open retroperitoneal lymph node dissection for testicular cancer: A comparison of clinical and perioperative outcomes.

Authors:  Toshihide Shishido; Takatsugu Okegawa; Kenjiro Hayashi; Kazuki Masuda; Satoru Taguchi; Yu Nakamura; Mitsuhiro Tambo; Hiroshi Fukuhara
Journal:  Asian J Urol       Date:  2021-05-25

Review 2.  The age of robotic surgery - Is laparoscopy dead?

Authors:  Hartwig Schwaibold; Felix Wiesend; Christian Bach
Journal:  Arab J Urol       Date:  2018-07-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.